Eptifibatide
Product Images NDC 25021-409

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 25021-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ept01 0001 01)

FDA Label Image

Figure 1 (Ept01 0001 02)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0001 03)

Package Label – Principal Display Panel – Vial Label (Ept01 0001 03)
This is a description of a medication called Eptifibatide. It is an injection used for intravenous use only and comes in a single-use vial containing 100 mL. The concentration of the medication is 0.75 mg per mL, containing a total of 79 mg per 100 mL. The medication is labeled by LAB-02015100 and has an NDC code of 25021-408-51. The text includes some unclear characters.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0001 04)

Package Label – Principal Display Panel – Vial Label (Ept01 0001 04)
This appears to be a product description for a medication called Eptifibatide. The text contains information on dosage and packaging, as well as a National Drug Code (NDC) number. The medication is intended for intravenous use only, and comes in a single-use 10 mL vial with a concentration of 2 mg per mL. The rest of the text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.